AI assistant
Sending…
VERACYTE, INC. — Director's Dealing 2020
Aug 5, 2020
31551_dirs_2020-08-04_04451cb4-d22b-449b-af5f-9bfa70352f2c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2020-07-31
Reporting Person: Hanna John Walter JR (Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-31 | Common Stock | M | 14095 | $8.86 | Acquired | 88729 | Direct |
| 2020-07-31 | Common Stock | S | 14095 | $36.1224 | Disposed | 74634 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-07-31 | Stock Option (right to buy) | $8.86 | M | 14095 | Disposed | 2025-03-01 | Common Stock (14095) | Direct |
Footnotes
F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019.
F2: Includes 110 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
F3: Represents weighted average sales price. Sale prices for the transactions range from $36.00 to $36.35. Detailed information regarding the number of shares sold at each separate price will be provided to the
SEC, the issuer or a shareholder upon request.
F4: The option is fully vested.
More from VERACYTE, INC.
Interim / Quarterly Report
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 25